Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery
1 other identifier
interventional
15
1 country
1
Brief Summary
Surgery for colorectal cancer is a major surgery. People above the age of 60 tend to have a higher risk of complications. Some studies indicate that senior cancer patients might benefit from a home support after surgery by a geriatric nurse practitioner and a team, beside their usual post-operative care. The investigators team is planning a large study to assess whether this approach could help patients with colorectal cancer recover better from their surgery, get better cancer treatment after that (e.g. chemotherapy), and possibly live longer. This study you are asked to take part in is a pilot for this large study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable colorectal-cancer
Started Dec 2008
Longer than P75 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 11, 2011
CompletedFirst Posted
Study publicly available on registry
August 12, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 27, 2013
November 1, 2013
4.3 years
August 11, 2011
November 26, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of the Intervention
The primary end-point for the pilot will be the feasibility of the intervention, measured as follows: * A compliance of \>=90% with the intervention table on page 17 * A success rate (improvement or resolution of problems) of \>= 80% * A completion rate of \>=90% of the initial and final study questionnaires
30 days per participant
Secondary Outcomes (3)
Whether the Intervention is Faithful to Dr. McCorkle's Original Intervention
30 days per participant
A Successful Collection and Testing of >=90% of the Samples Tested
30 days per participant
Effect Size Estimates for Within-group Changes Between Baseline and 1-month
30 days per participant
Study Arms (2)
Control Arm
NO INTERVENTIONUsual post-surgical care
Intervention arm
EXPERIMENTALIn addition to usual post-surgical care, the patients will receive a 4 week geriatric nurse practitioner-centered intervention, based on the McCorkle model.
Interventions
The intervention will consist each week in a home visit and a phone call. The GNP conducting the home visit will identify current problems using a comprehensive geriatric assessment (CGA) and record problems on the Intervention and Recommendation Data Sheet. In addition, the cases will be reviewed at a weekly Intervention Team meeting between the intervention GNP (VM, CV), the geriatrician (VP), and the intervention PI (JO). That team meeting will also record how intervention goals for the various problems are met, using the instruments and criteria developed during our pilot study5. To ensure optimal consistency and an up-to-date evidence-based approach over the 4 years of the intervention, treatment recommendations will be offered according to national evidence-based treatment guidelines.
Eligibility Criteria
You may qualify if:
- Colorectal cancer, stage III or IV, confirmed by histology
- Abdominal surgery by a University of South Florida (USF) surgeon at Moffitt Cancer Center or Tampa General Hospital (TGH)
- Age 60 years and older
- Informed consent
- Living within a one (1) hour radius of Moffitt
You may not qualify if:
- Discharge planned to a rehabilitation facility or a nursing home
- Unable to answer the questionnaires (e.g. because of cognitive impairment, blindness, deafness)
- Post-operative inpatient stay \>one (1) month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- H. Lee Moffitt Cancer Center and Research Institutelead
- Tampa General Hospitalcollaborator
- University of South Floridacollaborator
- Yale Universitycollaborator
Study Sites (1)
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martine Extermann, M.D., Ph.D.
H. Lee Moffitt Cancer Center and Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2011
First Posted
August 12, 2011
Study Start
December 1, 2008
Primary Completion
April 1, 2013
Study Completion
November 1, 2013
Last Updated
November 27, 2013
Record last verified: 2013-11